Our approach confirmed the association of NOTCH1 mutations with disease progression and shorter survival in oligodendroglioma, and further uncovered aberrant regulation of Notch and PI3K pathways as most strongly associated with advanced disease. The gene discussed is NOTCH1; the disease is oligodendroglioma.